Immucor CEO De Chirico
This article was originally published in The Gray Sheet
Executive Summary
Chairman Edward Gallup will take over CEO duties "on an interim basis" from Gioacchino De Chirico while the firm conducts an internal investigation related to "alleged improper cash payments" by Immucor and other firms, made "in exchange for favorable contract awards" by an Italian hospital, the firm says. De Chirico will retain his other title of president during the investigation, which parallels a criminal investigation by Italian authorities. The hospital administrator apparently had received an improperly documented payment of about $17,000 to organize an Immucor-sponsored convention, according to the company...
You may also be interested in...
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.
Metsera Launches As New Obesity Contender Flush With $290m
Clive Meanwell, former CEO of The Medicines Company, will helm the new company, backed by ARCH and other investors. He talked to Scrip about the new venture.
Deal Watch: AbbVie Teams With MedinCell On Long-Acting Injectables
Collaboration Edition: Including deals involving Evotec/Variant, Sanofi/IGM/Nurix, ABVC/OncoX and Harmony/Bioprojet, along with tech transfer agreements and deals in brief.